Recent scientific and public press reports have heightened awareness of the Zika virus and its emergence in the Americas. The temporal link between the emergence of the virus in Brazil and the birth of babies with microcephaly is most alarming. The Plasma Protein Therapeutics Association (PPTA) is aware that persons who rely on plasma protein therapies are understandably concerned whether these therapies are safe with respect to the Zika virus.
Read the latest information on the Zika Virus and medicines derived from human plasma (C1 inhibitor concentrate) here.
